Literature DB >> 8944624

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly.

J S Beckman1, W H Koppenol.   

Abstract

Nitric oxide contrasts with most intercellular messengers because it diffuses rapidly and isotropically through most tissues with little reaction but cannot be transported through the vasculature due to rapid destruction by oxyhemoglobin. The rapid diffusion of nitric oxide between cells allows it to locally integrate the responses of blood vessels to turbulence, modulate synaptic plasticity in neurons, and control the oscillatory behavior of neuronal networks. Nitric oxide is not necessarily short lived and is intrinsically no more reactive than oxygen. The reactivity of nitric oxide per se has been greatly overestimated in vitro because no drain is provided to remove nitric oxide. Nitric oxide persists in solution for several minutes in micromolar concentrations before it reacts with oxygen to form much stronger oxidants like nitrogen dioxide. Nitric oxide is removed within seconds in vivo by diffusion over 100 microns through tissues to enter red blood cells and react with oxyhemoglobin. The direct toxicity of nitric oxide is modest but is greatly enhanced by reacting with superoxide to form peroxynitrite (ONOO-). Nitric oxide is the only biological molecule produced in high enough concentrations to out-compete superoxide dismutase for superoxide. Peroxynitrite reacts relatively slowly with most biological molecules, making peroxynitrite a selective oxidant. Peroxynitrite modifies tyrosine in proteins to create nitrotyrosines, leaving a footprint detectable in vivo. Nitration of structural proteins, including neurofilaments and actin, can disrupt filament assembly with major pathological consequences. Antibodies to nitrotyrosine have revealed nitration in human atherosclerosis, myocardial ischemia, septic and distressed lung, inflammatory bowel disease, and amyotrophic lateral sclerosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8944624     DOI: 10.1152/ajpcell.1996.271.5.C1424

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  1079 in total

1.  Protracted elevation of neuronal nitric oxide synthase immunoreactivity in axotomised adult pudendal motor neurons.

Authors:  A H Pullen; P Humphreys
Journal:  J Anat       Date:  1999-05       Impact factor: 2.610

2.  Damage to the enteric nervous system in experimental colitis.

Authors:  S Sanovic; D P Lamb; M G Blennerhassett
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 3.  Endothelial nitric oxide in humans in health and disease.

Authors:  P Vallance; A Hingorani
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

4.  Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: evidence for selective impairment of myofibrillar creatine kinase.

Authors:  Michael J Mihm; Fushun Yu; David M Weinstein; Peter J Reiser; John Anthony Bauer
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

5.  Acute hyperglycemia induces an oxidative stress in healthy subjects.

Authors:  R Marfella; L Quagliaro; F Nappo; A Ceriello; D Giugliano
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

6.  Proteomic method identifies proteins nitrated in vivo during inflammatory challenge.

Authors:  K S Aulak; M Miyagi; L Yan; K A West; D Massillon; J W Crabb; D J Stuehr
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

7.  Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action.

Authors:  T Lauer; M Preik; T Rassaf; B E Strauer; A Deussen; M Feelisch; M Kelm
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

8.  In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies.

Authors:  T H Hung; J N Skepper; G J Burton
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 9.  Hyperglycemia and heart dysfunction: an oxidant mechanism contributing to heart failure in diabetes.

Authors:  K Esposito; R Marfella; D Giugliano
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

10.  The nitric oxide donor SIN-1 is free of tolerance and maintains its cyclic GMP stimulatory potency in nitrate-tolerant LLC-PK1 cells.

Authors:  B Hinz; H Schröder
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.